psilocybin has been researched along with mdl 100907 in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (27.27) | 29.6817 |
| 2010's | 2 (18.18) | 24.3611 |
| 2020's | 6 (54.55) | 2.80 |
| Authors | Studies |
|---|---|
| Carter, OL; Hasler, F; Liu, GB; Pettigrew, JD; Vollenweider, FX; Wallis, GM | 1 |
| Fantegrossi, WE; Katz, EB; Reissig, CJ; Rice, KC; Winter, JC; Yarosh, HL | 1 |
| Bray, JK; Goddard, WA | 1 |
| Bachmann, R; Kometer, M; Schmidt, A; Seifritz, E; Studerus, E; Vollenweider, FX | 1 |
| Jalal, B | 1 |
| Andreasen, JT; Kristensen, JL; Odland, AU | 1 |
| Atanasovski, D; Eriksson, E; Hagsäter, SM; Näslund, J; Pettersson, C; Pettersson, R | 1 |
| de la Fuente Revenga, M; Elder, H; González-Maeso, J; Jaster, AM; Marsh, SA; Negus, SS | 1 |
| Garza, G; Moghaddam, B; Olson, RJ; Torrado Pacheco, A | 1 |
| Botvinnik, A; Lerer, B; Lifschytz, T; Lotan, A; Saban, M; Salama, A; Shahar, O; Singh, S; Wolf, G; Yakobi, C | 1 |
| O'Grady, C | 1 |
1 review(s) available for psilocybin and mdl 100907
| Article | Year |
|---|---|
The neuropharmacology of sleep paralysis hallucinations: serotonin 2A activation and a novel therapeutic drug.
Topics: Animals; Dopamine; Hallucinations; Hallucinogens; Humans; Lysergic Acid Diethylamide; Neuropharmacology; Piperidines; Psilocybin; Receptor, Serotonin, 5-HT2A; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Sleep; Sleep Paralysis; Urea | 2018 |
1 trial(s) available for psilocybin and mdl 100907
| Article | Year |
|---|---|
Psilocybin biases facial recognition, goal-directed behavior, and mood state toward positive relative to negative emotions through different serotonergic subreceptors.
Topics: Adult; Affect; Cerebral Cortex; Double-Blind Method; Electroencephalography; Emotions; Evoked Potentials; Female; Goals; Hallucinogens; Humans; Ketanserin; Male; Neuropsychological Tests; Psilocybin; Receptors, Serotonin; Recognition, Psychology; Serotonin 5-HT2 Receptor Antagonists | 2012 |
9 other study(ies) available for psilocybin and mdl 100907
| Article | Year |
|---|---|
Psilocybin links binocular rivalry switch rate to attention and subjective arousal levels in humans.
Topics: Adult; Arousal; Attention; Double-Blind Method; Drug Combinations; Female; Hallucinogens; Humans; Ketanserin; Male; Psilocybin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Vision Disparity; Vision, Binocular | 2007 |
Hallucinogen-like effects of N,N-dipropyltryptamine (DPT): possible mediation by serotonin 5-HT1A and 5-HT2A receptors in rodents.
Topics: Animals; Data Interpretation, Statistical; Discrimination Learning; Dose-Response Relationship, Drug; Fluorobenzenes; Hallucinogens; Lysergic Acid Diethylamide; Male; Mice; N-Methyl-3,4-methylenedioxyamphetamine; Piperazines; Piperidines; Psilocybin; Pyridines; Rats; Rats, Inbred F344; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Serotonin Antagonists; Tryptamines | 2008 |
The structure of human serotonin 2c G-protein-coupled receptor bound to agonists and antagonists.
Topics: Amino Acid Sequence; Binding Sites; Humans; Kinetics; Metergoline; Methiothepin; Molecular Sequence Data; Mutagenesis; Protein Structure, Secondary; Psilocybin; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Ritanserin; Serotonin; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Structure-Activity Relationship; Thermodynamics | 2008 |
Investigating the role of 5-HT2A and 5-HT2C receptor activation in the effects of psilocybin, DOI, and citalopram on marble burying in mice.
Topics: Aminopyridines; Amphetamines; Animals; Behavior, Animal; Citalopram; Compulsive Behavior; Disease Models, Animal; Female; Fluorobenzenes; Indoles; Mice; Piperidines; Psilocybin; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2C; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin Antagonists | 2021 |
A Complex Impact of Systemically Administered 5-HT2A Receptor Ligands on Conditioned Fear.
Topics: Animals; Behavior, Animal; Bridged Bicyclo Compounds; Conditioning, Classical; Fear; Fluorobenzenes; Ligands; Male; Methylamines; Piperidines; Psilocybin; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists; Urea | 2021 |
Effects of the 5-HT
Topics: Animals; Depression; Fluorobenzenes; Hallucinogens; Lysergic Acid Diethylamide; Mescaline; Mice; Phenethylamines; Piperidines; Psilocybin; Rats; Receptor, Serotonin, 5-HT2A; Rodentia; Self Stimulation; Serotonin; Tryptamines | 2022 |
Acute psilocybin enhances cognitive flexibility in rats.
Topics: Animals; Anxiety; Cognition; Female; Hallucinogens; Ketanserin; Male; Psilocybin; Rats; Serotonin; Serotonin 5-HT2 Receptor Antagonists | 2023 |
Effect of psilocybin on marble burying in ICR mice: role of 5-HT1A receptors and implications for the treatment of obsessive-compulsive disorder.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Animals; Buspirone; Escitalopram; Hallucinogens; Male; Mice; Mice, Inbred ICR; Obsessive-Compulsive Disorder; Psilocybin; Receptor, Serotonin, 5-HT1A; Serotonin | 2023 |
No trip needed for psychedelics to lift mood?
Topics: Animals; Antidepressive Agents; Brain; Hallucinogens; Humans; Lysergic Acid Diethylamide; Mice; Psilocybin; Receptor, Serotonin, 5-HT2A; Receptor, trkB; Serotonin 5-HT2 Receptor Antagonists | 2023 |